πŸ‡ΊπŸ‡Έ FDA
Patent

US 10588936

Modulators of complement activity

granted A61KA61K38/10A61K39/00

Quick answer

US patent 10588936 (Modulators of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RA PHARMACEUTICALS, INC.
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/10, A61K39/00, A61P, A61P25/00